PMA device
Minima Stent System
Renata Medical, Inc. · Aortic Stent (PNF, Class III) · First FDA decision Aug 28, 2024, newest Aug 27, 2026Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
Breakthrough-designated
Device trials
1,494
Naming "Minima"
MAUDE reports
29
Brand "Minima", since 2015
PubMed studies
11,424
Mentioning "Minima"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Minima Stent System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Minima Stent System; Minima Pro Stent SystemPMA supplement
P240003-S008 · Decided Aug 27, 2026 · 42 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic stent (PNF) · Cardiology
- Minima Stent SystemPMA supplement
P240003-S001 · Decided Nov 8, 2024 · 46 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic stent (PNF) · Cardiology
- Minima Stent System and Minima Pro Stent SystemBreakthroughPMA
P240003 · Decided Aug 28, 2024 · 180 days after receipt
Device type: Aortic stent (PNF) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- MolDX: Minimal Residual Disease Testing for CancerLocal determinationIn effectL38822CGS Administrators, LLCUpdated Oct 29, 2026
- Select Minimally Invasive GERD ProceduresLocal determinationIn effectL35080Wellpoint FederalUpdated Jul 14, 2026
- Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) JointLocal determinationIn effectL36406Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
- MolDX: Minimal Residual Disease Testing for CancerLocal determinationIn effectL38814Noridian Healthcare Solutions, LLCUpdated Jan 26, 2026
- MolDX: Minimal Residual Disease Testing for CancerLocal determinationIn effectL38835WPS Insurance CorporationUpdated Oct 21, 2025
- Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)Local determinationIn effectL39810Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)Local determinationIn effectL39797Palmetto GBAUpdated Jun 12, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Minima", any status and sponsor, newest update first.
Edwards LifesciencesPublic (EW)
NCT03170349 · 124 participants · Start Jun 27, 2017 · Primary completion Jul 30, 2020
Device: Mitral Valve Repair · For: Mitral Valve Regurgitation
Sites: Los Angeles, California; Aurora, Colorado; Evanston, Illinois · 17 sites in all
National Cancer Institute (NCI)NIH
NCT05642195 · 30 participants (planned) · Start Nov 24, 2026 · Primary completion Dec 30, 2033
Device: Ventana PD-L1 (SP263 or SP142) assay · For: Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung and 1 more
Sites: Bethesda, Maryland
General University Hospital, PragueAcademic, hospital or other
NCT07939061 · 47 participants (planned) · Start Sep 3, 2026 · Primary completion Jun 1, 2028
Device: Active peroneal transcutaneous neuromodulation (URIS I, Stimvia); Sham peroneal transcutaneous neuromodulation (URIS I, Stimvia) · For: Overactive Bladder; Daytime Urinary Incontinence
Sites: Prague, Czechia
1,491 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Minima", and for the whole product code for context.
This brand
29 reports: 15 malfunction, 13 injury, 1 death
Whole product code PNF
92 reports: 73 malfunction, 18 injury, 1 death
Newest reports for this brand
- Reciproc Minima R20, 21mm - 6 Pack STERILEMalfunction
Maillefer Instruments Holding S.a.r.l.
8031010-2026-00664 · Received Oct 30, 2026
Device type: File, Pulp Canal, Endodontic (EKS)
Device problem as coded: Break
Patient problem as coded: Device Embedded In Tissue or Plaque
- Minima Stent SystemInjury
3027098402-2026-00007 · Received Sep 16, 2026 · Event dated Aug 6, 2026
Device type: Aortic Stent (PNF)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- RECIPROC MINIMA R25 21mm 6 FILESMalfunction
MAILLEFER INSTRUMENTS HOLDING SARL
8031010-2026-00121 · Received Aug 3, 2026 · Event dated Jun 17, 2026
Device type: File, Pulp Canal, Endodontic (EKS)
Device problem as coded: Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Minima"[tiab]. The summary above synthesizes these.
- [Not Available].
Barrientos-Gutiérrez I, Cruz-Jiménez L, Gallegos-Carrillo K, et al. · Salud Publica Mex · 2023English Abstract
- GRAMMCell: Docking-based Cell Modeling Resource.
Singh A, Tytarenko AM, Ambati VK, et al. · J Mol Biol · 2025Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Local Minima in Factor Rotations.
Nguyen HV, Waller NG · Multivariate Behav Res · 2022
- Mindless chemistry.
Bera PP, Sattelmeyer KW, Saunders M, et al. · J Phys Chem A · 2006
- Energy landscapes and persistent minima.
Carr JM, Mazauric D, Cazals F, et al. · J Chem Phys · 2016Research Support, Non-U.S. Gov't
- New cytotoxic withanolides from Physalis minima.
Zhang M, Jiang B, He X, et al. · Fitoterapia · 2020
- [Thalassaemia minima].
PREMUZIC M · Lijec Vjesn · 1962
- [Thalassemia minima].
GATTO I, VALENTINO L · Boll Soc Ital Biol Sper · 1952
- Correction: Centipeda minima active components and mechanisms in lung cancer.
Gao C, Pan H, Ma F, et al. · BMC Complement Med Ther · 2024Published Erratum
- Centipeda minima active components and mechanisms in lung cancer.
Gao C, Pan H, Ma F, et al. · BMC Complement Med Ther · 2023
- Medicinal Plant Centipeda Minima: A Resource of Bioactive Compounds.
Linh NTT, Ha NTT, Tra NT, et al. · Mini Rev Med Chem · 2021Review
- A systematic study of minima in alanine dipeptide.
Mironov V, Alexeev Y, Mulligan VK, et al. · J Comput Chem · 2019Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
Other devices of this type
Also filed under product code PNF.
- Cheatham Platinum (CP) Stent System (Covered CP StentNuMED, Inc. · PMA 2017
- Minima Pro Stent SystemRenata Medical, Inc. · PMA 2026
- CP Stent (Model 425)NuMED, Inc. · PMA 2026
- G-Armor StentNuMED, Inc. · PMA 2021
- NuDel Delivery SystemNuMED, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.